Literature DB >> 20487368

Current status and clinical presentations of invasive neonatal Group B streptococcal infections in Korea.

Kyung Hee Park1, Kyung Hyo Kim, Jin Han Kang, Kwang Nam Kim, Dong Soo Kim, Yun Kyung Kim, Jung Soo Kim, Jong Hyun Kim, Chang Hwi Kim, Hwang Min Kim, Sung Hee Oh, Eun Hee Chung, Sung Ho Cha, Young Youn Choi, Jae Kyun Hur, Young Jin Hong, Su Eun Park, Hoan Jong Lee.   

Abstract

BACKGROUND: Group B streptococcus (GBS) is the most common cause of invasive neonatal infections in developed countries. The incidence of early-onset GBS disease in Korea is known to be much lower than that in other developed countries; however neonatal GBS disease has been frequently reported in recent years in Korea. This retrospective study sought to determine the current status and clinical presentation of neonatal GBS disease in Korea.
METHODS: From January 1996 through December 2005, GBS cases (n= 157) diagnosed in blood, cerebrospinal fluid, or other sterile body fluids among infants <3 months of age from 14 university hospitals in Korea were identified. Age of onset, diagnosis, underlying medical conditions, and outcomes were investigated by reviewing the medical records.
RESULTS: A total of 157 cases were identified during the study period. Of the cases, 32 were early-onset disease (EOD) and 125 were late-onset disease (LOD). Twenty-six of the EOD cases had symptoms during the first 24 h after birth. One hundred of the 157 GBS cases were diagnosed as meningitis. The mortality rate of EOD was 20.7%. The case fatality rate of LOD was 7.2% and 25.2% of LOD cases had sequelae.
CONCLUSIONS: GBS is becoming an important cause of invasive neonatal infections in Korea, with LOD being more common. It may not be currently necessary to adopt the prevention guidelines of perinatal GBS disease in Korea. However, studies of maternal GBS carriage rates and neonatal GBS disease will continue.
© 2011 The Authors. Pediatrics International © 2011 Japan Pediatric Society.

Entities:  

Mesh:

Year:  2011        PMID: 20487368     DOI: 10.1111/j.1442-200X.2010.03165.x

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  5 in total

1.  Estimating the burden of invasive Group B Streptococcal disease in young infants in southern mainland China: an observational study.

Authors:  Haiying Liu; Houlin Zeng; Weidong Wang; Qiulan Deng; Immaculada Margarit; C Daniela Rinaudo; Todd Swarthout; Marianne Cunnington; Wenjing Ji; Guozhu Geng
Journal:  Int J Clin Exp Med       Date:  2015-08-15

2.  Prevention of neonatal group B streptococcal disease.

Authors:  Su Eun Park
Journal:  Infect Chemother       Date:  2013-09

3.  Epidemiology of invasive group B streptococcal disease in infants from urban area of South China, 2011-2014.

Authors:  Xiaoshan Guan; Xiaoping Mu; Wenjing Ji; Chunlei Yuan; Ping He; Lian Zhang; Yanfen Huang; Juan Li; Jianfeng Chen; Huamin Zhong; Shuyin Pang; Nan Tan; Qiulian Deng; Kankan Gao; Yu-Ping Huang; Chien-Yi Chang; Haiying Liu
Journal:  BMC Infect Dis       Date:  2018-01-08       Impact factor: 3.090

4.  Recent Epidemiological Changes in Group B Streptococcus Among Pregnant Korean Women.

Authors:  Seong Jin Choi; Jieun Kang; Young Uh
Journal:  Ann Lab Med       Date:  2021-07-01       Impact factor: 3.464

Review 5.  Infant Group B Streptococcal Disease Incidence and Serotypes Worldwide: Systematic Review and Meta-analyses.

Authors:  Lola Madrid; Anna C Seale; Maya Kohli-Lynch; Karen M Edmond; Joy E Lawn; Paul T Heath; Shabir A Madhi; Carol J Baker; Linda Bartlett; Clare Cutland; Michael G Gravett; Margaret Ip; Kirsty Le Doare; Craig E Rubens; Samir K Saha; Ajoke Sobanjo-Ter Meulen; Johan Vekemans; Stephanie Schrag
Journal:  Clin Infect Dis       Date:  2017-11-06       Impact factor: 20.999

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.